The claim that cleansing the liver leads to weight loss is mechanistically incoherent
GH, epidermal growth factor, basic fibroblast growth factor)[7072], nutrition[73, 74], and injury (hypoxic/ischemic, stereotactic, electrolytic and cryogenic injuries, as well as induced demyelination and experimental autoimmune encephalomyelitis)[7581], influence its in vivo brain expression
Hepatology Studies: Investigating the peptides role in reducing hepatic fat accumulation in animal models
No Observed Effects On: Blood glucose or insulin sensitivity (no diabetogenic effects) IGF-1 levels (remained within normal ranges) Blood pressure or cardiovascular parameters Thyroid function Liver or kidney function markers Important: The absence of growth hormone-related side effects distinguishes AOD-9604 from full-length GH, which can cause fluid retention, joint pain, carpal tunnel syndrome, and insulin resistance
But a dual-target nanobody that shows clear efficacy in one major indication isn't nothing